InvestorsHub Logo

elysse1kittycat

08/01/15 10:19 AM

#86947 RE: homeslice10 #86946

If it turns out to be a waste of time, then so be it.
At least I can face myself and say that I did the right thing.
I am and have always been a fighter for what I believe to be right and even more so when my own money is involved and at stake!

chuckanutman

08/01/15 10:58 AM

#86948 RE: homeslice10 #86946

It's been mentioned before, maybe Japan's patients need help with OCATA technology. Here is some quotes from the web about the subject.

"Ocata Competitor's AMD ips stem cell trial halted due to cancer scare"


https://www.newscientist.com/article...ure-blindness/

"As I said on another thread Japan should immediately partner with Ocata and bring in the real experts!"

BF


"the good Dr. robert is getting marketing savvy...love his quote.."

“I think it’s an easily fixable problem if they go this route,” says Robert Lanza, chief scientist at Advanced Cell Technology/OCAT in Marlborough, Massachusetts, a company that is also developing stem-cell therapies for age-related blindness"

"This sounds horrible, but the failure of these trials will ultimately help Ocata a lot. One by one, the inferior and not-ready-for-prime time stem cell treatments are falling. And since this is the treatment I would need... well, I think I have the cred to say it!!"

"Well the cell source used in the Japanese trials used ips cell derived using viral vectors to alter the cell back to its embryonic like state and the ips cells Ocata is using uses mRNA to alter it which Lanza has always said was the safe way to derive these cells. Maybe your response was retorical and you knew this already but if there's anyone that didn't know the difference between Ocatas technique and Japan's, there it is."